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Learning objectives 
At the end of the article, you should be able to understand the following 
• The integrated structure of the innate and adaptive immune system 
• How pattern recognition receptors of the innate immune system select and guide 
immune responses to particular pathogens 
• How the nature of the immune defect predisposes to particular kinds of infections 
in primary immune deficiencies 
Abstract 
The immune system in mammals has two facets – the innate and adaptive immune 
system - which function as a complex, interdependent entity. This has only recently been 
fully appreciated when it was realised that the innate immune system has the ability to 
“sample” micro-organisms via its pattern recognition receptors (PRRs) that recognise 
pathogen associated molecular patters (PAMPs) – structures present on pathogens but not on 
mammalian cells. Once activated, PRRs such as Toll-like receptors (TLRs), C-type lectins 
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and others activate signalling pathways and gene transcription programmes that lead to 
production of appropriate chemical messengers (cytokines, chemokines etc) that activate the 
most appropriate immune responses for protection against a particular microorganism. The 
adaptive immune system mounts cell-mediated responses to deal with intracellular 
microorganisms (e.g. mycobacteria, viruses etc) and/or humoral (antibody) responses to 
combat extracellular microorganisms (Streptococci, Haemophilus etc). Primary immune 
deficiencies predispose to different infections, depending on the nature of the underlying 
immune defect (e.g. combined immune deficiency, antibody deficiency, autoinflammatory 
syndromes). Recent recognition of how subtle immune defects predispose to infections with 
only selected, weak pathogens (“non-classical primary immune deficienies”) have enhanced 
our understanding of immunity to infection. Understanding mechanisms underlying the 
immune response to infection will improve diagnosis and treatment.  
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Structure of the immune system 
The immune system has evolved to protect the individual organism from “non-self”, 
which in natural circumstances mostly pertains to invading microorganisms (bacteria, viruses, 
fungi, parasites etc). Initially, the evolutionarily older, innate immune system was formed and 
remains the only protection in species up to primitive fish (colostoma). It consists of an array 
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of biologically active molecules (such as complement, cytokines, chemokines etc) and 
phagocytic cells (such as macrophages, neutrophils etc) that are able to identify and destroy 
harmful intruders. The innate immune system is very quick, reacting in minutes rather than 
hours, and induces a highly efficient inflammatory response. However, it lacks specificity 
and memory, because of which responses are not fine-tuned and subsequent responses to the 
same intruder will not be improved (quicker and more efficient). The innate immune system 
in this form has been retained in species that have gone on to evolve a more sophisticated, 
adaptive immune system, which includes antigen-presenting cells (such as dendritic cells - 
DCs) and lymphocytes - T cells, B cells and Natural-Killer cells. T lymphocytes have well 
characterised subsets, including T-helper, T-cytotoxic and T-regulatory cells. The adaptive 
immune system recognises (mostly) protein targets coined antigens and boasts exceptional 
specificity, distinguishing structural differences encoded even by only one amino acid.  It 
also boasts memory, enabling it to improve specificity and speed of response when it 
encounters the same antigen on a subsequent occasion [1] [2]. 
 
Role of the innate immune response in infection 
In response to infection, the innate immune system mounts an inflammatory response 
by triggering cells to produce biologically active chemical mediators such as cytokines (also 
known as interleukins) and chemokines, which enable cell-cell communication / co-
ordination as well as directly mediating biological effects such as cell activation, chemotaxis, 
vasodilatation etc. The adaptive immune system on the other hand, has evolved two distinct 
strategies to deal with infection: cell-mediated responses (delivered by effector T-cytotoxic 
and T-helper cells that recruit phagocytes) which target intracellular microorganisms and 
humoral responses (delivered by antibodies produced by B lymphocytes), which target 
extracellular microorganisms [2]. 
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Pattern recognition receptors 
It has only recently been recognised that the innate and adaptive immune system are 
very closely functionally linked and that it is the “primitive” innate immune system that 
actually guides and instructs how the adaptive immune system will respond to a particular 
type of microorganism. This is achieved by the innate immune’s ability to “sample” 
microorganisms via pattern-recognition receptors (PRRs) on mammalian cells which 
recognise pathogen-associated molecular patterns (PAMPs) – vital structures specific to 
microorganisms but alien to mammals, that cannot be readily modified or mutated without 
consequence [3]. Different PRRs trigger distinct signalling pathways, leading to production 
of selected panels of cytokines and chemokines which then lead to activation of appropriate 
mechanisms of the adaptive immune response, ensuring that the strategy employed is the 
appropriate one for eradicating that particular microorganism.  If efficient protection requires 
cell-mediated immunity i.e. recruitment of T-cytotoxic and phagocytic cells, the innate 
immune system will recruit T-helper 1 (Th1) cells that produce cytokines such as interferon 
gamma (IFNγ), interleukin (IL)-12 and tumour necrosis factor alpha (TNFα) which activate 
monocytes and macrophages. If antibodies are required, the innate immune system will 
secrete cytokines such as IL-4, IL-5, IL-13 and IL-10, inducing a Th2 type response ensuring 
activation of B cells and antibody production [1].  
PRRs can be divided into several categories depending on localisation and function. 
Soluble PRRs include mannan binding lectin (MBL) and C-reactive protein (CRP) which act 
as opsonins to neutralise and clear pathogens through activation of complement [4]. 
Intracellular PRRs such as NOD-like receptors (NLRs) are composed of more than 20 
proteins which together form the “inflammasome”  that is activated by bacterial products [5]. 
To date, the most studied PRRs are the transmembrane, cell-surface receptors which include 
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Toll-like receptors (TLRs) 1-10 and C-type lectin receptors (CLRs) such as the mannose 
receptor (MR), Dectin-1, Dectin-2 etc. TLRs and CTLs are signalling receptors where ligand 
recognition activates signalling cascades that leads to gene expression programs with 
differential activation of cytokine and chemokine production. All TLRs (except TLR3) share 
the adaptor MyD88 leading to activation of nuclear factor (NF)-κB, mitogen-activated 
protein (MAP)-kinases and interferon-releasing factor 3 (IRF3), stimulating Th1 responses 
through production of IL-12, IFNγ, tumour necrosis factor (TNFα) and type 1 IFNs [6]. TLR 
1, 2, 4 and 5 are present on the plasma membrane and recognise bacterial components, while 
the anti-viral TLR 3, 7, 8 and 9 are expressed in intracellular compartments [4] [7]. TLR 1, 2 
and 6 recognise lipopeptides, TLR4 lipopolysaccharide (LPS), TLR5 flaggelin, TLR7 and 8 
single-stranded RNA and TLR9 unmethylated CpG. TRL3 double-stranded RNA. TLR 1, 2, 
4 and 5 are present on the plasma membrane and recognise bacterial components, while the 
anti-viral TLR 3, 7, 8 and 9 are expressed in intracellular compartments [4] and Fig 1 
(http://www.nature.com/nri/focus/tlr/nri1397.html). 
 
Infections due to deficiencies of the innate immune system 
The importance of the innate immune response in human infection has long been 
assumed, although evidence has only recently accumulated through reports of specific genetic 
defects and ensuing pathology. Patients with defects of cytokines or cytokine receptors for 
IL-12 and IFNγ are susceptible to infections with intracellular microorganisms such as 
mycobacteria and Salmonella; disorders of the complement pathway predisposes to Neisseria 
infections; disorders of TLR3 and UNC-93B-IFN-α/β pathway confers selective 
predisposition to herpes simplex virus (HSV) encephalitis [8]. The importance of TLRs in 
protection against infection has been recently confirmed in patients with MyD88 deficiency, 
who suffer with recurrent pyogenic bacterial infections [9]; deficiencies of the NLR 
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inflammasome components lead to a range of auto-inflammatory syndromes, that have only 
recently been elucidated [5] as the cause of diseases such as Familial Mediteranian Fever, 
Cold Familial auto-inflammatory syndrome etc, while defects in the Dectin-1 pathway have 
only recently been shown to predispose to chronic Candida infections  [10]. 
 
Role of the adaptive immune response in infection 
As mentioned above, the innate immune system initiates the inflammatory process 
trigerred by invading microorganisism, which is both protective and leads to appropriate 
activation of the adaptive immune system toward a Th1 or Th2 type response, resulting in 
cell-mediated or antibody-mediated immunity. T cells express antigen-specific cell-surface 
receptors that recognise only processed (not free) antigen, presented in the context of major-
histocompatibility (MHC) molecules (HLA in humans – Human Leucocyte Antigen) on 
antigen-presenting cells (APCs) such as dendritic cells (DCs). CD4 T lymphocytes recognise 
antigen in the context of MHC-class II alleles, expressed only on APCs, while CD8 T 
lymphocytes recognise antigen in the context of MHC-class I alleles, expressed on all 
nucleated cells.  
The basis of the adaptive immune response is clonal selection, where a T cell, 
activated by recognising it’s specific antigen, proliferates, producing a clone of T cells with 
the same specificity, thus providing an antigen-specific response. Antigens presented by 
MHC-class II on APCs are mostly exogenous antigens, taken up by APCs, while antigens 
presented by MHC-class I are mostly endogenous, although there is evidence of cross-
presentation. This ensures that all nucleated cells can present microbial (e.g. viral) 
endogenous antigens which can be recognised by cytotoxic T cells (mostly CD8) and 
destroyed in case of infection. T-helper (mostly CD4) lymphocytes are activated either to 
promote cell-mediated immunity (Th1 cells) which produce inflammatory cytokines (such as 
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IFNγ) and chemokines that recruit and activate macrophages, neutrophils and other cells to 
the site of  infection or Th2 cells which promote antibody production by B cells. Recently, 
another type of T-helper cell with a major role in cell-mediated immune responses has been 
identified, coined Th17, which secretes IL-17 and IL-17 inducing cytokines (IL-21, IL-22 
etc) that have a major role in infection as well as in autoimmunity [11]. Cell-mediated Th1 
responses are crucial for protection from intracellular microorganisms such as mycobacteria 
and viruses. IL-17 plays a role in protection against Gram-negative bacteria (Klebsiella, 
Psudomonas, E. Colli etc) and fungal infections [12]. In contrast, Th2 cells promote B cell 
differentiation by secreting IL-4, IL-5 and IL-13, which leads to production of antibodies 
IgM, IgG and IgA (and IgE and IgD in certain  circumstances) [1]. Most B cell responses are 
T cell dependent so that optimal antibody production cannot develop in the absence of T 
lymphocytes. Much attention has recently focused on T regulatory cells (Treg) which have 
different origins and function and seem to be crucial in ending and limiting the immune 
response once the pathogen has been cleared [13]. 
 
Infections due to deficiencies of the adaptive immune system 
Defects that undermine the development of the adaptive immune system cause major 
immune deficiency and susceptibility to infection depending on the nature of the underlying 
defect. Failure to develop both T and B lymphocytes results in the fatal phenotype of Severe 
Combined Immune Deficiency (SCID), with profound immune deficiency from the first days 
of life, usually presenting with defects of cell-mediated immunity and susceptibility to viral 
and fungal (Candida thrush) infections. SCID can be caused by more than 15 known gene 
mutations, which cause profound immune defects incompatible with life, that can only be 
treated with life-saving bone-marrow transplantations. Isolated T cell defects are not 
recognised because of the dependency of an optimal B cell response on T cell help. However, 
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(more-or-less) isolate humoral i.e. antibody defects are recognised and present with profound 
susceptibility to infection, with encapsulated, pyogenic bacteria (Streptococci, Hemophilus) 
and certain viruses (Entero viruses) where protection relies on antibody opsonisation for the 
destruction of the microorganisms. Replacement therapy with intravenous immunoglobulins 
has hugely improved outcome and quality of life in these patients, although susceptibility to 
infections and other (autoimmune diseases) remains higher  than in healthy individuals, 
strongly suggesting that there is still a lot we don’t know about the role of B lymphocytes in 
infection and immunity. 
 
Non-classical primary immune deficiencies 
Recently, a new and intriguing concept of non-conventional primary immune 
deficiencies (PIDs) has been put forward [8], defining these as a selective susceptibility to a 
single weakly pathogenic or opportunistic organism. Surprisingly, in these PIDs, a 
predisposition to a single type of infection is caused by immune defects affecting pathways 
central to the immune response. Examples include disorders mentioned above, such as 
defects of the interleukin (IL)-12/interferon (IFN)γ circuit resulting in selective susceptibility 
to infections with mycobacteria and Salmonella; defects in the TLR3 pathway resulting in 
selective predisposition to Herpes Simplex Virus (HSV) infection; MyD88 deficiency and 
susceptibility to pyogenic bacterial infections. The infectious phenotype that the above 
disorders confer in humans is much narrower than those of corresponding mutant mice, 
suggesting there is much redundancy in human host defence in nature [8], [9]. Our own work 
in patients with Chronic Mucocutaneous Candidiasis, who suffer with selective susceptibility 
to infections with the fungus Candida suggests that defects of DC cytokine production, 
maturation and / or PRR cell signalling pathways may underly this still elusive non-
conventional PID [14]. 
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Taken together, we have only recently begun appreciating the complexities of 
interactions between the innate and adaptive immune system in response to infection and the 
flexibility our immune system has to allow it to select the most efficient response to a 
particular pathogen. We are also becoming more aware of subtle immune defects, 
predisposing to infections with only particular pathogens, persuading us to redefine our 
understanding of infection and primary immune deficiencies. Understanding mechanisms 
underlying the immune response to infection will improve diagnosis and treatment of patients 
in the future. 
Word count 1883 
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